Resumen del trabajo presentado al VII Congreso Red Española Canales Iónicos: Symposium 3: Calcium signaling and Cell Function, celebrado en Cáceres del 15 al 17 de mayo de 2019.Supported by SAF2014-57190R; Spanish Society of Cardiology (SEC) and FPU17/06135.Peer Reviewe
Darko Duplancic,1 Marijan Cesarik,2 Nikola Kolja Poljak,3 Maja Radman,4 Vedran Kovacic,5 Josipa Radi...
Secondary hyperparathyroidism (SHPT) is a common complication in patients with chronic kidney disea...
Cardiovascular diseases are more prevalent in patients with chronic kidney disease than in the gener...
Resumen del trabajo presentado al European Heart Rhythm Association Congress (EHRA) celebrado en Lis...
[Background and Purpose]: The synthetic vitamin D3 analogue paricalcitol acts as a selective activat...
Background and Purpose The synthetic vitamin D3 analog paricalcitol acts as a selective activator o...
<p>(A) Representative hearts in 1α-OHase<sup>−/−</sup> mice with or without PC treatment after 4 wee...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];有審查制度[[note]]http://gateway.isiknowledge.com/gateway/Gateway...
O estudo investigou a influência do tratamento de 10 semanas com paricalcitol (0,1µg/kg 5x/semana) e...
ResumenEl hiperparatiroidismo secundario (HPTS) es una complicación habitual en pacientes con enferm...
Cardiovascular (CV) morbidity and mortality are significantly higher in patients with chronic kidney...
Secondary hyperparathyroidism is a systemic disorder that associates with bone and cardiovascular di...
Vitamin D seems to protect against cardiovascular disease, but the reported effects of vitaminDon pa...
Background: Heart failure (HF) is known to be a major medical problem in the Western world with incr...
Cardiovascular (CV) morbidity and mortality are significantly higher in patients with chronic kidney...
Darko Duplancic,1 Marijan Cesarik,2 Nikola Kolja Poljak,3 Maja Radman,4 Vedran Kovacic,5 Josipa Radi...
Secondary hyperparathyroidism (SHPT) is a common complication in patients with chronic kidney disea...
Cardiovascular diseases are more prevalent in patients with chronic kidney disease than in the gener...
Resumen del trabajo presentado al European Heart Rhythm Association Congress (EHRA) celebrado en Lis...
[Background and Purpose]: The synthetic vitamin D3 analogue paricalcitol acts as a selective activat...
Background and Purpose The synthetic vitamin D3 analog paricalcitol acts as a selective activator o...
<p>(A) Representative hearts in 1α-OHase<sup>−/−</sup> mice with or without PC treatment after 4 wee...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];有審查制度[[note]]http://gateway.isiknowledge.com/gateway/Gateway...
O estudo investigou a influência do tratamento de 10 semanas com paricalcitol (0,1µg/kg 5x/semana) e...
ResumenEl hiperparatiroidismo secundario (HPTS) es una complicación habitual en pacientes con enferm...
Cardiovascular (CV) morbidity and mortality are significantly higher in patients with chronic kidney...
Secondary hyperparathyroidism is a systemic disorder that associates with bone and cardiovascular di...
Vitamin D seems to protect against cardiovascular disease, but the reported effects of vitaminDon pa...
Background: Heart failure (HF) is known to be a major medical problem in the Western world with incr...
Cardiovascular (CV) morbidity and mortality are significantly higher in patients with chronic kidney...
Darko Duplancic,1 Marijan Cesarik,2 Nikola Kolja Poljak,3 Maja Radman,4 Vedran Kovacic,5 Josipa Radi...
Secondary hyperparathyroidism (SHPT) is a common complication in patients with chronic kidney disea...
Cardiovascular diseases are more prevalent in patients with chronic kidney disease than in the gener...